DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced it has completed its previously announced majority share acquisition of CareCentrix, Inc.—the leading independent home-centered platform that coordinates care to the home for health plans, patients and providers. The majority investment in CareCentrix accelerates Walgreens Health’s capabilities in delivering quality healthcare across a spectrum of settings including primary care, specialty pharmacy ca
Related Posts
Pfizer’s Legal Threats: A Governance Crisis Unfolds
Corporate Governance Scrutiny: Pfizer's legal threats against former executives Ian Read and Frank D'Amelio for collaborating with activist investor Starboard Value have raised concerns about...
Sanofi’s $16B Consumer Health Unit Deal: A Strategic OTC Shift
Strategic Shift: Sanofi's $16.4B deal to sell 50% stake in Opella consumer health unit to CD&R signals strategic focus on innovative medicines and vaccines. Industry Trend: Major pharma players like...
Pfizer’s Critical Turnaround: Activist Pressure and the Path Forward
Activist Pressure: Pfizer faces mounting pressure from activist investor Starboard Value's $1 billion stake, sparking strategic revamp. Internal Revitalization: BMO analyst recommends "fixing what...
Bausch + Lomb Mulls Sale: A Simpler Journey Ahead?
Strategic Pivot: Bausch + Lomb's exploration of a sale represents a strategic shift from its tumultuous spin-off process, aiming to streamline operations and unlock value. Market Positioning: With a...